Close

Ratings by Morgan Stanley (Mark Purcell)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/22/2024 AstraZeneca AZN Maintain Overweight
(N/A)
 
 
  Details
4/15/2024 Novo Nordisk NVO Maintain Overweight
(N/A)
 
 
  Details
2/16/2024 Novartis NVS Maintain Equalweight
(N/A)
 
 
  Details
1/23/2024 Novartis NVS New Coverage Equalweight
(N/A)
108.23
(97.28)
-10.12% Details
1/23/2024 Sanofi-Aventis SNY New Coverage Equalweight
(N/A)
51.03
(47.69)
-6.55% Details
1/23/2024 GlaxoSmithKline GSK New Coverage Equalweight
(N/A)
39.68
(41.24)
3.93% Details
1/23/2024 Novo Nordisk NVO New Coverage Overweight
(N/A)
106.96
(128.64)
20.27% Details
1/23/2024 AstraZeneca AZN New Coverage Overweight
(N/A)
66.54
(70.85)
6.48% Details
6/16/2021 GlaxoSmithKline GSK Maintain Equalweight
(N/A)
 
 
  Details